Pakistan | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Pakistan totalled $ 306 million in 2023. Sales of commodity group 30 from Pakistan decreased by 0.768% in value terms compared to 2022. exports of commodity group 30 "Pharmaceutical products" decreased by $ 2.37 million (cumulative exports of commodity group 30 from Pakistan amounted $309 million in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 1.06% of total exports from Pakistan (cumulative merchandise exports from Pakistan totalled $ 28 billion in 2023). The share of commodity group 30 in total exports from Pakistan increased by 0.062 p.p. compared to 2022 (it was 1% in 2022 and cumulative exports from Pakistan were equal to $ 30 billion).
Where does Pakistan export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Pakistan in 2023:
- Afghanistan with a share of 36% (112 million US$)
- Philippines with a share of 8.18% (25 million US$)
- Sri Lanka with a share of 6.82% (20 million US$)
- Uzbekistan with a share of 5.2% (15.9 million US$)
- Cambodia with a share of 4.52% (13.8 million US$)
- France with a share of 3.66% (11.2 million US$)
- Kenya with a share of 2.73% (8.39 million US$)
- Iraq with a share of 2.47% (7.58 million US$)
- Singapore with a share of 2.38% (7.3 million US$)
- Vietnam with a share of 2.33% (7.16 million US$)
Exports structure of 30 - Pharmaceutical products - from Pakistan in 2023 represented by the following main commodity groups:
- 92% (284 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 5.77% (17.7 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 1.33% (4.08 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.033% (102 thousand US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 0.009% (28 thousand US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
The value of imports of commodity group 30 "Pharmaceutical products" to Pakistan totalled $ 719 million in 2023. Sales of commodity group 30 to Pakistan decreased by 43% in value terms compared to 2022. imports of commodity group 30 "Pharmaceutical products" decreased by $ 542 million (the value of imports of commodity group 30 to Pakistan was equal to $1.26 billion in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 1.43% of total import flow to Pakistan (in 2023, total imports to Pakistan amounted to $ 50 billion). The share of commodity group 30 in total imports to Pakistan decreased by 0.359 p.p. compared to 2022 (it was 1.79% in 2022 and cumulative imports to Pakistan were equal to $ 70 billion).
Where does Pakistan import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Pakistan in 2023:
- Belgium with a share of 18.9% (135 million US$)
- India with a share of 10.6% (76 million US$)
- France with a share of 9.31% (66 million US$)
- Germany with a share of 8.76% (63 million US$)
- USA with a share of 8.6% (61 million US$)
- China with a share of 8.14% (58 million US$)
- Switzerland with a share of 7.41% (53 million US$)
- Italy with a share of 6.34% (45 million US$)
- Korea with a share of 2.6% (18.6 million US$)
- Denmark with a share of 2.09% (15 million US$)
Imports structure of 30 - Pharmaceutical products - to Pakistan in 2023 represented by the following main commodity groups:
- 48% (350 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 45% (323 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 2.99% (21 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 2.1% (15.1 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.961% (6.91 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.117% (843 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
